Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Johnson & Johnson (JNJ) Tops Q3 Earnings and Revenue Estimates
08:35am, Tuesday, 15'th Oct 2024
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.66 per share a year ago.
Nipocalimab demonstrates sustained disease control in adolescents living with generalized myasthenia gravis in Phase 2/3 study
08:00am, Tuesday, 15'th Oct 2024
First FcRn blocker to demonstrate sustained disease control over 24 weeks in antibody positive adolescents aged 12 – 17 years, broadening the population in which nipocalimab has been studied SAVA
Johnson & Johnson stock rises on Q3 sales beat and guidance raise
07:18am, Tuesday, 15'th Oct 2024
Johnson & Johnson shares rose 0.7% in premarket trades Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance.
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
06:25am, Tuesday, 15'th Oct 2024
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2024 of $1.24 per share on the co
J&J lifts profit and sales forecasts, beats Wall Street expectations
06:22am, Tuesday, 15'th Oct 2024
Johnson & Johnson raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and quarterly results that beat Wall Street expectations.
Johnson & Johnson Reports Q3 2024 Results
06:20am, Tuesday, 15'th Oct 2024
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2024. “Johnson & Johnson's strong results in the third quarter reflect the unique breadt
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
01:48pm, Monday, 14'th Oct 2024
Johnson & Johnson JNJ will release earnings results for its third quarter before the opening bell on Tuesday, Oct. 15.
Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals
10:14am, Monday, 14'th Oct 2024
Johnson & Johnson JNJ is set to announce its third quarter earnings on Oct. 15 before the market opens. Wall Street is expecting the pharmaceutical and healthcare giant to post earnings per share (EPS
Best Pharma Stocks for Long-Term Investors: Growth and Dividends
07:01am, Monday, 14'th Oct 2024
The size of the pharmaceutical industry in the U.S. in 2023 was estimated to be nearly $575 billion, with an anticipated compound growth rate of about 5.5% through 2030. This key component of the heal
Johnson & Johnson Q3 Earnings Preview: Dividend Dependability And Steady Growth
05:19pm, Friday, 11'th Oct 2024
Johnson & Johnson's Q3 2024 earnings report will highlight its MedTech division, driven by strategic acquisitions and R&D investments in cardiovascular and orthopedic solutions. Despite lagging behind
Retirees: Focus on Dividend Growth With These 3 Stocks
01:35pm, Friday, 11'th Oct 2024
Dividend stocks are among the top assets long-term investors want to consider when it comes to building a stable income-generating portfolio over time.
What Trends Will Drive Johnson & Johnson's Q3 Results?
07:00am, Friday, 11'th Oct 2024
Johnson & Johnson stock (NYSE: JNJ) will report its Q3 2024 results on Tuesday, October 15. We expect the company to post revenue of $22.2 billion and earnings of $2.20 per share, broadly aligning wit
What You Need to Know Ahead of Johnson & Johnson's Earnings
05:10am, Friday, 11'th Oct 2024
Johnson & Johnson (JNJ) reports earnings Tuesday morning for the third quarter, with analysts expecting the company's revenue and profit to rise year-on-year.
J&J talc bankruptcy stays in Texas despite 'forum-shopping" opposition
06:16pm, Thursday, 10'th Oct 2024
A Johnson & Johnson subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc products caused cancer in a Texas bankruptcy court, a judge ruled on Thursday, al
Johnson & Johnson to Participate in the Stifel 2024 Healthcare Conference
04:30pm, Thursday, 10'th Oct 2024
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the Stifel 2024 Healthcare Conference on Monday, November 18th, at the Lotte New York Palace in New York. Michae
